×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.

Become an Incathlab member and receive full access to its content!

You must be an Incathlab member to access videos without any restrictions. Register for free in one minute and access all services provided by Incathlab.You will also be able to log into Incathlab from your Facebook or twitter account by clicking on login on the top-right corner of Incathlab website.

Registration Login


Case summary

Patient Demographics
Age: 66 years old
Gender: male
 
Medical History
NIDDM; Hypertension; Dyslipidaemia
Previous smoking history
Previous femoral PTCA
Known IHD: 
1998: Anterior STEMI - Thrombolysis + PCI of proximal LAD (BMS)
2002: CTO of RCA: medical management
2016: ICD (EF 35% + NSVT)
 
Clinical Presentation
Stable angina (CCS III)
Nuclear perfusion imaging: inducible ischaemia of infero-lateral wall
 
Coronary angio
Normal LM
LAD:
moderate ISR (FFR 0.79) 
severe stenosis mid-LAD 
PCI with two overlapping DESs 
M1: severe stenosis
RCA: CTO of proximal segment with septal collaterals from LAD

Strategy

ACCESSES
Radial: XB 3.5 6Fr 90 cm
Femoral: AL1 7Fr 100 cm; long sheath

APPROACHES
Retrograde approach through septal collaterals (Turnpike LP and Sion)
Retrogade true-to-true
Retrograde dissection and re-entry
Antegrade dissection reentry
Antegrade approach with guidewire escalation

Protocol: OptiRAY (Ioversol)

Concentration: 350 mgl/mL
Volume: 220 mL

 

 


 

Shooting date : 2017-01-26
Last update : 2021-06-09

Suggestions

Wednesday, July 5th 2023 from 06pm to 07pm (GMT+2)
Honolulu : Wednesday, July 5th 2023 from 07am to 08am (GMT+2)
San Francisco : Wednesday, July 5th 2023 from 10am to 11am (GMT+2)
New York : Wednesday, July 5th 2023 from 01pm to 02pm (GMT+2)
Buenos Aires : Wednesday, July 5th 2023 from 02pm to 03pm (GMT+2)
Reykjavik : Wednesday, July 5th 2023 from 05pm to 06pm (GMT+2)
London / Dublin : Wednesday, July 5th 2023 from 06pm to 07pm (GMT+2)
Paris / Berlin : Wednesday, July 5th 2023 from 07pm to 08pm (GMT+2)
Istanbul : Wednesday, July 5th 2023 from 08pm to 09pm (GMT+2)
Moscou / Dubaï : Wednesday, July 5th 2023 from 09pm to 10pm (GMT+2)
Bangkok : Thursday, July 6th 2023 from 12am to 01am (GMT+2)
Shanghai : Thursday, July 6th 2023 from 01am to 02am (GMT+2)
Tokyo : Thursday, July 6th 2023 from 02am to 03am (GMT+2)
Sydney : Thursday, July 6th 2023 from 04am to 05am (GMT+2)
Wellington : Thursday, July 6th 2023 from 06am to 07am (GMT+2)

Left Main and Bifurcation treatment:

impact of clinical trials in daily practice

Share
Wednesday, May 22nd 2024 from 03pm to 04pm (GMT+2)
Honolulu : Wednesday, May 22nd 2024 from 04am to 05am (GMT+2)
San Francisco : Wednesday, May 22nd 2024 from 07am to 08am (GMT+2)
New York : Wednesday, May 22nd 2024 from 10am to 11am (GMT+2)
Buenos Aires : Wednesday, May 22nd 2024 from 11am to 12pm (GMT+2)
Reykjavik : Wednesday, May 22nd 2024 from 02pm to 03pm (GMT+2)
London / Dublin : Wednesday, May 22nd 2024 from 03pm to 04pm (GMT+2)
Paris / Berlin : Wednesday, May 22nd 2024 from 04pm to 05pm (GMT+2)
Istanbul : Wednesday, May 22nd 2024 from 05pm to 06pm (GMT+2)
Moscou / Dubaï : Wednesday, May 22nd 2024 from 06pm to 07pm (GMT+2)
Bangkok : Wednesday, May 22nd 2024 from 09pm to 10pm (GMT+2)
Shanghai : Wednesday, May 22nd 2024 from 10pm to 11pm (GMT+2)
Tokyo : Wednesday, May 22nd 2024 from 11pm to 12am (GMT+2)
Sydney : Thursday, May 23rd 2024 from 01am to 02am (GMT+2)
Wellington : Thursday, May 23rd 2024 from 03am to 04am (GMT+2)

DanGER shock trial results and the significance to reduce adverse events

Share
Monday, October 30th 2023 from 05pm to 06pm (GMT+1)
Honolulu : Monday, October 30th 2023 from 06am to 07am (GMT+1)
San Francisco : Monday, October 30th 2023 from 08am to 09am (GMT+1)
New York : Monday, October 30th 2023 from 11am to 12pm (GMT+1)
Buenos Aires : Monday, October 30th 2023 from 01pm to 02pm (GMT+1)
London / Dublin : Monday, October 30th 2023 from 04pm to 05pm (GMT+1)
Paris / Berlin : Monday, October 30th 2023 from 05pm to 06pm (GMT+1)
Istanbul : Monday, October 30th 2023 from 06pm to 07pm (GMT+1)
Moscou / Dubaï : Monday, October 30th 2023 from 08pm to 09pm (GMT+1)
Bangkok : Monday, October 30th 2023 from 11pm to 12am (GMT+1)
Shanghai : Tuesday, October 31st 2023 from 12am to 01am (GMT+1)
Tokyo : Tuesday, October 31st 2023 from 01am to 02am (GMT+1)
Sydney : Tuesday, October 31st 2023 from 02am to 03am (GMT+1)
Wellington : Tuesday, October 31st 2023 from 04am to 05am (GMT+1)

How do the new antithrombotic recommendations affect your HBR patients?

Gain insights from a patient case analysis

Share
Wednesday, June 21st 2023 from 04pm to 05:30pm (GMT+2)
Honolulu : Wednesday, June 21st 2023 from 05am to 06:30am (GMT+2)
San Francisco : Wednesday, June 21st 2023 from 08am to 09:30am (GMT+2)
New York : Wednesday, June 21st 2023 from 11am to 12:30pm (GMT+2)
Buenos Aires : Wednesday, June 21st 2023 from 12pm to 01:30pm (GMT+2)
Reykjavik : Wednesday, June 21st 2023 from 03pm to 04:30pm (GMT+2)
London / Dublin : Wednesday, June 21st 2023 from 04pm to 05:30pm (GMT+2)
Paris / Berlin : Wednesday, June 21st 2023 from 05pm to 06:30pm (GMT+2)
Istanbul : Wednesday, June 21st 2023 from 06pm to 07:30pm (GMT+2)
Moscou / Dubaï : Wednesday, June 21st 2023 from 07pm to 08:30pm (GMT+2)
Bangkok : Wednesday, June 21st 2023 from 10pm to 11:30pm (GMT+2)
Shanghai : Wednesday, June 21st 2023 from 11pm to 12:30am (GMT+2)
Tokyo : Thursday, June 22nd 2023 from 12am to 01:30am (GMT+2)
Sydney : Thursday, June 22nd 2023 from 02am to 03:30am (GMT+2)
Wellington : Thursday, June 22nd 2023 from 04am to 05:30am (GMT+2)

Strategies and techniques to treat multivessel disease with complex lesions

Share
Scroll Up